德纳维制药 (DVAX.O)

+ 收藏

资产负债表(德纳维制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 123112311231123112311231
原始币种 美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见112,501,000.00132,033,000.00
 应收账款及票据(元) 会员可见会员可见会员可见会员可见61,654,000.0044,161,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见22,284,000.0021,781,000.00
 存货(元) 会员可见会员可见会员可见会员可见62,462,000.0061,806,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见623,111,000.00591,505,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见882,012,000.00851,286,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见36,105,000.0036,413,000.00
 商誉(元) 会员可见会员可见会员可见会员可见2,007,000.002,022,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见96,197,000.0096,844,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见134,309,000.00135,279,000.00
总资产(元) 会员可见会员可见会员可见会员可见1,016,321,000.00986,565,000.00
流动负债:
 应付账款及票据(元) 会员可见会员可见会员可见会员可见4,555,000.002,431,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见53,069,000.0048,978,000.00
 流动负债其他项目(元) 会员可见会员可见会员可见会员可见4,568,000.004,593,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见62,192,000.0056,002,000.00
非流动负债:
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见27,473,000.0028,559,000.00
 其他长期应付款(元) 会员可见会员可见会员可见会员可见60,337,000.0060,337,000.00
 衍生工具负债非流动(元) 会员可见会员可见会员可见会员可见223,272,000.00222,984,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见198,000.00203,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见311,280,000.00312,083,000.00
总负债(元) 会员可见会员可见会员可见会员可见373,472,000.00368,085,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见131,000.00131,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见1,575,548,000.001,562,027,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-927,919,000.00-939,305,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见-4,911,000.00-4,373,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见642,849,000.00618,480,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见642,849,000.00618,480,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见1,016,321,000.00986,565,000.00
公告日期 2025-08-072025-05-062025-02-202024-11-072024-08-062024-05-08
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院